Connect your AI

Avalo Therapeutics AVTX Lessee Operating Lease Discount Rate

Lessee Operating Lease Discount Rate at other companies

BlackstoneBX

3.5%—

American International GroupAIG

3.2%—

Carrier GlobalCARR

4.6%+0.1pp

The Travelers CompaniesTRV

4.1%+0.3pp

MSCIMSCI

4.4%+0.3pp

3MMMM

3.5%0.0pp

Other financials

Income statement

Revenue$59.0K-69.3%

Gross profit$963.0K+8,855%

Operating income-$20.9M-42.5%

Net income-$19.6M-49.3%

EPS (diluted)-$0.98+21.6%

Balance sheet

Cash & equivalents$25.3M-79.8%

Total debt$328.0K-59.1%

Total equity$68.3M-44.3%

Total assets$99.9M-27.9%

Cash flow

Operating cash flow-$17.7M-87.1%

CapEx-—

Free cash flow-$15.0M-444%

Valuation

Market cap$946.18M+1,783%

Enterprise value$921.19M-1,342%

P/S1,892.4×+1,852×

Profitability

Gross margin182%+176pp

Operating margin-15,536.1%-17,275pp

Net margin-7,965.8%-10,750pp

FCF margin-11,123.8%-13,374pp

Returns & leverage

Return on equity-88.8%—

Debt / equity0×0.0×

Current ratio7.7×-14.9×

Where this comes from

Reported directly by Avalo Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseDiscountRate.

The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's lessee operating lease discount rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Avalo Therapeutics's lessee operating lease discount rate?: Avalo Therapeutics (AVTX) reported lessee operating lease discount rate of $0.11 in Q1 2026.
How has Avalo Therapeutics's lessee operating lease discount rate changed year-over-year?: Avalo Therapeutics's lessee operating lease discount rate increased by 9.4% year-over-year, from $0.1 to $0.11.